Australia In Vivo Cro Market Size & Outlook, 2024-2030
Australia in vivo cro market, 2018-2030 (US$M)
Related Markets
Australia in vivo cro market highlights
- The Australia in vivo cro market generated a revenue of USD 30.3 million in 2023 and is expected to reach USD 53.5 million by 2030.
- The Australia market is expected to grow at a CAGR of 8.5% from 2024 to 2030.
- In terms of segment, small molecule was the largest revenue generating modality type in 2023.
- Large Molecule is the most lucrative modality type segment registering the fastest growth during the forecast period.
In vivo cro market data book summary
| Market revenue in 2023 | USD 30.3 million |
| Market revenue in 2030 | USD 53.5 million |
| Growth rate | 8.5% (CAGR from 2023 to 2030) |
| Largest segment | Small molecule |
| Fastest growing segment | Large Molecule |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
| Key market players worldwide | IQVIA Holdings Inc, JSR Corp, Taconic Biosciences, Evotec SE, Janvier Labs, Charles River Laboratories International Inc, Icon PLC, Labcorp Holdings Inc, PAREXEL, GemPharmatech, PsychoGenics, Biocytogen, SMO-Group |
Other key industry trends
- In terms of revenue, Australia accounted for 0.7% of the global in vivo cro market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan in vivo cro market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 122.7 million by 2030.
Small molecule was the largest segment with a revenue share of 63.7% in 2024. Horizon Databook has segmented the Australia in vivo cro market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.
The Department of Health and industry stakeholders are collaborating to improve Australia’s clinical research and trial environment. The initiatives include receiving funding support from the Medical Research Future Fund to develop drug discovery centers, benefitting from favorable R&D tax incentives, and implementing streamlined regulatory pathways. These factors are expected to drive Australia’s in vivo CRO market during the forecast period.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In Vivo CRO Market Scope
In Vivo CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia in vivo cro market size, by modality type, 2018-2030 (US$M)
Australia In Vivo CRO Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
